@ARTICLE{
author={Schuster Michael W,Rigas James R,Orlov Sergey V,Milovanovic Branislav M,Prabhash Kumar,Smith Jeffrey T},
year={2010},
title={ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={28},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Rigas James R,Schuster Michael W,Orlov Sergey V,Milovanovic Branislav M,Prabhash Kumar,Smith Jeffrey T},
year={2010},
title={Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={28},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Schuster Michael W,Rigas James R,Orlov Sergey V,Milovanovic Branislav M,Prabhash Kumar,Smith Jeffrey T},
year={2010},
title={Inhibition of Interleukin-6 (IL-6) Reverses Anemia In Patients with Advanced Non Small Cell Lung Cancer (NSCLC): Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial},
journal={BLOOD},
volume={116},
number={21},
pages={281-281},
document_type={Meeting Abstract},
}